ClinicalTrials.Veeva

Menu

Efficacy of 308-nm Excimer Laser for Primary Localized Cutaneous Amyloidosis Treatment in Asians

C

Chulalongkorn University

Status

Unknown

Conditions

Lichen Amyloidosis

Treatments

Radiation: 308-nm excimer laser

Study type

Interventional

Funder types

Other

Identifiers

NCT03068156
CU_308excimer_amyloidosis

Details and patient eligibility

About

Efficacy of 308-nm excimer laser for primary localized cutaneous amyloidosis treatment in Asians, pilot study.

Enrollment

15 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients, aged >18 years old with lichen amyloidosis diagnosed by using clinical presentation and pathologic features

Exclusion criteria

  • Those with cutaneous amyloidosis associated systemic diseases
  • Pregnancy or lactating woman
  • Those who are allergic to urea, olive oil
  • Those who are photosensitive to ultraviolet radiation
  • Those who had been previously treated with medications/ radiation/ laser within 3 months for systemic and 1 month for topical therapy

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

15 participants in 2 patient groups

excimer laser
Experimental group
Treatment:
Radiation: 308-nm excimer laser
Control
No Intervention group

Trial contacts and locations

1

Loading...

Central trial contact

Pravit Asawanonda, M.D., PhD; Einapak Amnarttrakul, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems